Progression to hepatitis and fibrosis secondary to lomitapide use: selecting the next course of action
- PMID: 25178868
- DOI: 10.1001/jamainternmed.2014.1538
Progression to hepatitis and fibrosis secondary to lomitapide use: selecting the next course of action
Comment in
-
Progression to hepatitis and fibrosis secondary to lomitapide use--reply.JAMA Intern Med. 2014 Sep;174(9):1522-3. doi: 10.1001/jamainternmed.2014.1528. JAMA Intern Med. 2014. PMID: 25178869 No abstract available.
Comment on
-
Severe hypertriglyceridemia with pancreatitis: thirteen years' treatment with lomitapide.JAMA Intern Med. 2014 Mar;174(3):443-7. doi: 10.1001/jamainternmed.2013.13309. JAMA Intern Med. 2014. PMID: 24366202
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical